BAX and colonic neoplasm: This is the first report showing that TPO-NANO enhanced the sensitivity of cancer cells to Oxa and triggered programmed cell death through ROS-mediated Bax translocation leading to mitochondrial apoptosis pathway in p53 wild-type and mutant type colon cancer cells.